Walder Wyss has advised Energie 360°; VISCHER acted as legal counsel to Primeo Energie, Groupe E and ewb. Energie 360° has completed the acquisition of Move...
Energie 360° Acquires Move Mobility to Strengthen Swiss Mobility Group
synaforce Group Acquires Swiss Cloud Platform ServerBase AG
VISCHER has advised the synaforce Group. The synaforce Group has completed the acquisition of ServerBase AG, a well-established cloud platform provider based in Switzerland. This transaction...
Invariant Labs Sold to Snyk
Wenger Vieli has advised the shareholders of Invariant Labs. VISCHER advised Snyk. The shareholders of Invariant Labs, a Zurich-based artificial intelligence security research firm and spin-off...
Easternmed Real Estate Capital Acquires Prime Hotel Residence in Geneva
VISCHER has advised Easternmed Real Estate Capital PLC. Easternmed Real Estate Capital PLC, a company listed on the Cyprus Stock Exchange Emerging Markets, has completed the...
Swissroc Industrial Opportunities Acquires Light Industrial Asset in Geneva
VISCHER has advised Swissroc Asset Management SA. Swissroc Industrial Opportunities (CH) SA has completed the acquisition of a 4,200 sq/m light industrial building situated in the...
Mosanna Therapeutics Completes USD 80 Million Series A Funding Round
VISCHER has advised Mosanna Therapeutics AG; Walder Wyss advised EQT Life Sciences. Mosanna Therapeutics AG has successfully closed its USD 80 million Series A funding round....
Thommen Group Acquires Wiederkehr Recycling Group
VISCHER has advised Thommen Group. The Thommen Group has completed the acquisition of 100% of the shares in Wiederkehr Recycling AG and its affiliated companies, including...
F24 Schweiz AG Acquires Imasys Business Unit from Swissphone Group
VISCHER has advised the Swissphone Group. On June 4, 2025, the Swissphone Group, with the support of Rigeto Unternehmerkapital, completed the sale of certain assets and...
GlycoEra Secures USD 130 Million in Series B Financing Led by Novo Holdings and LifeArc Ventures
BGPartner has advised Novo Holdings and LifeArc Ventures; VISCHER advised GlycoEra AG. GlycoEra Ltd, a Swiss biotechnology company specializing in innovative treatments for autoimmune diseases, has...
Aktiia Raises USD 42 Million in Series B to Support Global Expansion
VISCHER has advised Earlybird Health, Wellington Partners, Kfund, and naturalX Health Ventures. Aktiia, a company specializing in blood pressure intelligence technology, has successfully raised USD 42...
HAYA Therapeutics SA’s $65 Million Series A Funding Round
Lenz & Staehelin acted for Eli Lilly; Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital; VISCHER acted for HAYA Therapeutics AG. Wilson Sonsini Goodrich &...
MCH Group’s Joint Venture With Bits & Pretzels
VISCHER provided comprehensive legal advice to both partners on the formation of the joint venture company and the contractual framework of the new concept. MCH Group...